Improvements in irritability with sertraline versus placebo: Findings from the EMBARC study.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of affective disorders"
DOI: 10.1016/j.jad.2020.06.021
Abstract: BACKGROUND This report seeks to evaluate improvements in symptoms of irritability with sertraline (a selective serotonin reuptake inhibitor antidepressant) versus placebo. METHODS Participants of Establishing Moderators and Biosignatures of Antidepressant Response in Clinical Care (EMBARC)… read more here.
Keywords: irritability; irritability sertraline; sertraline placebo; versus placebo ... See more keywords